CNS Therapeutics ans Disease Concepts

Rainer MK, Mucke HAM, Zehetmayer S, et al.: Data from the VITA Study do not support the concept of vascular depression. Am J Geriatr Psychiatry 14(6): 531-537 (2006) PubMed link

Rainer MK, Mucke HAM, Masching AJ, et al.: State-of-the-art management of BPSD in dementia. Psychiatr Prax. 32(1): 31-8 (2005) PubMed link

Rainer MK, Mucke HAM, Kruger-Rainer C, et al.: Zotepine for behavioural and psychological symptoms in dementia: an open-label study. CNS Drugs 18(1): 49-55 (2004) PubMedlink

Mucke HAM: Rotigotine Schwarz Pharma. IDrugs 6(9): 894-9 (2003) PubMed link

Mucke HAM: Localisation and function of 5-HT2 receptors. IDrugs 5(8): 776-8 (2002)

Mucke HAM: Therapies in development for the treatment of migraine. Expert Opin Investig Drugs 11(12): 1813-20 (2002) PubMed link

Mucke HAM: Genomics and dementia - new drug targets ahead? J Neural Transm Suppl. (62): 287-91 (2002) PubMed link

Rainer MK, Mucke HAM, Kruger-Rainer C, et al.: Cognitive relapse after discontinuation of drug therapy in Alzheimer's disease: cholinesterase inhibitors versus nootropics. J Neural Transm. 108(11): 1327-33 (2001) PubMed link